This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
Dublin: 9 °C Tuesday 31 March, 2020

Study indicates diabetes drug could help slow progression of Parkinson's

Parkinson’s is the second largest neurological condition in Ireland.

Image: Title Photo via Shutterstock

A DRUG THAT’S used to treat people with diabetes could help those with Parkinson’s disease, a study in The Lancet has indicated.

Parkinson’s is a progressive disease of the nervous system that causes tremors, stiff muscles, and slow movements, which mostly affects middle-aged and elderly people.

Although there are ways of treating the symptoms, a way of slowing or stopping the disease from progressing hasn’t been found yet.

But this study, funded by the Michael J Fox Foundation for Parkinson’s Research, has indicated that a drug called Exenatide which is commonly used to treat type 2 diabetes appears to improve symptoms even after people stop taking the drug.

Parkinson’s disease affects around 12,000 people in Ireland, with that number expected to double in the next 20 years.

Parkinson’s is the second largest neurological condition in Ireland after Alzheimer’s.

Read: The number of blind people in the world is set to triple by 2050

  • Share on Facebook
  • Email this article

About the author:

Read next: